Adams Diversified Equity Fund’s Emergent Biosolutions EBS Stock Holding History

Adams Diversified Equity Fund’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,500	Closed	-$72K	–	124
2019 Q2	$72K	Sell	1,500 -1,700	-53%	-$81.5K	﹤0.01%	218
2019 Q1	$162K	Sell	3,200 -3,300	-51%	-$195K	0.01%	213
2018 Q4	$385K	Sell	6,500 -5,500	-46%	-$355K	0.02%	195
2018 Q3	$790K	Sell	12,000 -800	-6%	-$46.7K	0.04%	105
2018 Q2	$646K	Sell	12,800 -1,100	-8%	-$57.3K	0.03%	171
2018 Q1	$732K	Hold	13,900	–	–	0.04%	149
2017 Q4	$646K	Sell	13,900 -4,000	-22%	-$168K	0.03%	173
2017 Q3	$724K	Sell	17,900 -700	-4%	-$25.3K	0.04%	199
2017 Q2	$631K	Sell	18,600 -3,400	-15%	-$105K	0.04%	200
2017 Q1	$639K	Buy	22,000 +600	+3%	+$18.3K	0.04%	206
2016 Q4	$703K	Buy	21,400 +14,200	+197%	+$426K	0.04%	197
2016 Q3	$202K	Hold	7,200	–	–	0.01%	194
2016 Q2	$202K	Buy	+7,200	New	+$282K	0.01%	194

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Adams Diversified Equity Fund's EBS Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of Emergent Biosolutions (EBS) in Q3 2019, closing a stake of 1,500 shares — an estimated $72K sold.

Adams Diversified Equity Fund first reported a position in EBS in Q2 2016 and held it in 13 quarters. The position peaked at $790K in Q3 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

Adams Diversified Equity Fund reported no remaining Emergent Biosolutions position as of Q3 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 1,500 Emergent Biosolutions shares in Q3 2019, an estimated $72K.
Adams Diversified Equity Fund first reported a position in Emergent Biosolutions in Q2 2016 and held it in 13 quarters.
Adams Diversified Equity Fund's Emergent Biosolutions position peaked at $790K in Q3 2018.
244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.